|








| |

Implantable Cardioverter-Defibrillator Therapy for Prevention of Sudden Death in
Patients with Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
Circulation. 2003;108:3084-3091
Domenico
Corrado, MD, PhD; Loira Leoni, MD; Mark S. Link, MD; Paolo Della Bella, MD;
Fiorenzo Gaita, MD; Antonio Curnis, MD; Jorge Uriarte Salerno, MD; Diran
Igidbashian, MD; Antonio Raviele, MD; Marcello Disertori, MD; Gabriele
Zanotto, MD; Roberto Verlato, MD; Giuseppe Vergara, MD; Pietro Delise, MD;
Pietro Turrini, MD, PhD; Cristina Basso, MD, PhD; Franco Naccarella, MD;
Francesco Maddalena, MD; N.A. Mark Estes, III, MD; Gianfranco Buja, MD;
Gaetano Thiene, MD
In patients with ARVC/D, ICD therapy
provided life-saving protection by effectively terminating life-threatening
ventricular arrhythmias. Patients who were prone to ventricular
fibrillation/flutter could be identified on the basis of clinical presentation,
irrespective of programmed ventricular stimulation outcome.
Determinants of Sudden Cardiac Death in Individuals with the
Electrocardiographic Pattern of Brugada Syndrome and No Previous Cardiac Arrest
Circulation. 2003;108:3092-3096
Josep Brugada, MD, PhD; Ramon Brugada,
MD; Pedro Brugada, MD, PhD
Multivariate
analysis identified the inducibility of a sustained ventricular arrhythmia
(P<0.0001) and a history of syncope (P<0.01) as predictors of events.
Logistic regression analysis showed that a patient with a spontaneously abnormal
ECG, a previous history of syncope, and inducible sustained ventricular
arrhythmias had a probability of 27.2% of suffering an event during follow-up.
Use of automated external defibrillator by first responders in out of hospital
cardiac arrest: prospective controlled trial
BMJ 2003;327:1312
Anouk P van Alem, junior scientist, Rob H Vrenken, medical director,
municipal health service, Rien de Vos, clinical epidemiologist, Jan G P
Tijssen, clinical epidemiologist, Rudolph W Koster, lecturer in cardiology
Use of automated external defibrillators
by first responders did not significantly increase survival to discharge from
hospital, although it did improve return of spontaneous circulation and
admission to hospital. Improved dispatch procedures should increase the
success of programmes of first responders using external defibrillators.
Congenital Short QT Syndrome and Implantable Cardioverter Defibrillator
Treatment: Inherent Risk for Inappropriate Shock Delivery
Journal of Cardiovascular Electrophysiology Volume 14
Issue 12 Page 1273 - December 2003
RAINER SCHIMPF, M.D., CHRISTIAN WOLPERT, M.D., FRANCESCA BIANCHI, M.D.,
CARLA GIUSTETTO, M.D., FIORENZO GAITA, M.D., URS BAUERSFELD, M.D., and MARTIN
BORGGREFE, M.D.
The congenital short QT syndrome
constitutes a new clinical entity with an increased risk for sudden cardiac
death. Currently, ICD treatment is the only therapeutic option.
Implantable Cardioverter Defibrillator Events in Patients with Asymptomatic
Nonsustained Ventricular Tachycardia: Is Device Implantation Justified?
Pacing and Clinical Electrophysiology Volume 26 Issue 12
Page 2289 - December 2003
ANDREA M. RUSSO, HEMAL NAYAK, RALPH VERDINO, JAMIE SPRINGMAN, EDWARD
GERSTENFELD, HENRY HSIA, and FRANCIS E. MARCHLINSKI
Patients with coronary disease and
asymptomatic NSVT commonly receive appropriate defibrillator therapy. These results support the need for ICD
implantation for primary prevention, with attention to careful
programming of the detection rate to prevent inappropriate therapy.
Usefulness of ST-segment elevation in lead aVR during tachycardia for
determining the mechanism of narrow QRS complex tachycardia
Am J Cardiol 15 December 2003,
Volume 92, Issue 12 Pages 1424-1428
Yi-Lwun Ho, Lian-Yu Lin, Jiunn-Lee Lin, Ming-Fong Chen, Wen-Jone Chen
and Yuan-Teh Lee
aVR ST-segment elevation during narrow
QRS complex tachycardia favors the atrioventricular reentry through an accessory
pathway as the mechanism of the tachycardia.
Total Atrioventricular Nodal Ablation Increases Atrial Fibrillation Burden in
Patients with Paroxysmal Atrial Fibrillation Despite Continuation of
Antiarrhythmic Drug Therapy
Journal of Cardiovascular Electrophysiology Volume 14
Issue 12 Page 1296 - December 2003
RIK WILLEMS, M.D., D. GEORGE WYSE, M.D., Ph.D., and ANNE M. GILLIS,
M.D., for the Atrial Pacing Periablation for Paroxysmal Atrial Fibrillation
(PA3) Study Investigators
TAVN ablation increases AF burden and
facilitates the development of persistent AF in patients with paroxysmal AF
despite the continuation of antiarrhythmic drugs. Loss of AV and/or
interventricular synchrony may lead to altered cardiac hemodynamics resulting in
atrial stretch and increasing AF burden.
Left Atrial Radiofrequency Ablation During Cardiac Surgery in Patients with
Atrial Fibrillation
Journal of Cardiovascular Electrophysiology Volume 14
Issue 12 Page 1289 - December 2003
ROBERTO MANTOVAN, M.D., ANTONIO RAVIELE, M.D., GIANFRANCO BUJA, M.D.,
EMANUELE BERTAGLIA, M.D., FRANCESCO CESARI, M.D., ALESSANDRA PEDROCCO, M.D.,
CLAUDIO ZUSSA, M.D., GINO GEROSA, M.D., CARLO VALFRÈ, M.D., and PAOLO STRITONI,
M.D., on behalf of the North-eastern Italian Study on Radiofrequency Surgical
Treatment of Atrial Fibrillation Investigators
Endocardial RF
left atrial compartmentalization during cardiac surgery is effective in
restoring sinus rhythm in many patients. This technique is easy to perform and
reproducible. Rare RF ablation-related complications can occur. During
follow-up, sinus rhythm persistence is good, and biatrial contraction is
preserved in most patients.
Evaluation of the Appropriateness of Pacemaker Mode Selection in Bradycardia
Pacing: How Closely are the ACC/AHA Guidelines Followed?
Pacing and Clinical Electrophysiology Volume 26 Issue 12
Page 2301 - December 2003
MARLEEN E. IRWIN, KEVIN R. BAINEY, and MANOHARA P. J. SENARATNE
(1) elderly denied a dual chamber system
with no clinical explanation and (2)
selection of rate-modulated devices
without any indication of chronotropic incompetence.
Optimal Pacing for Symptomatic AV Block: A Comparison of VDD and DDD Pacing
Pacing and Clinical Electrophysiology Volume 26 Issue 12
Page 2230 - December 2003
MAX HUANG, ANDREW D. KRAHN, RAYMOND YEE, GEORGE J. KLEIN, and ALLAN C.
SKANES
The lower cost, high
reliability, and abbreviated implantation time suggest that VDD pacing is a
viable alternative to DDD pacing in patients with high-degree AV block and
normal sinus node function.
Long-term effectiveness of cardiac resynchronization therapy in patients with
refractory heart failure and “narrow” QRS
J Am Coll Cardiol 17 December
2003, Volume 42, Issue 12 Pages 2117-2124
Augusto
Achilli, Massimo Sassara, Sabina Ficili, Daniele Pontillo, Paola Achilli,
Claudio Alessi, Stefano De Spirito, Roberto Guerra, Nicolino Patruno and
Francesco Serra
Cardiac
resynchronization therapy determined clinical and functional benefit that was
similar in patients with wide or “narrow” QRS. Cardiac resynchronization therapy may be
helpful in patients with echocardiographic evidence of interventricular and
intraventricular asynchrony and incomplete left bundle branch block.
Noninvasive Arrhythmia Risk Stratification in Idiopathic Dilated Cardiomyopathy:
Results of the Marburg Cardiomyopathy Study
Circulation. 2003;108:2883
Wolfram
Grimm, MD; Michael Christ, MD; Jennifer Bach, MD; Hans-Helge Müller, PhD;
Bernhard Maisch, MD
Reduced LV ejection fraction and lack of
ß-blocker use are important arrhythmia risk predictors in IDC, whereas
signal-averaged ECG, baroreflex sensitivity, heart rate variability, and T-wave
alternans do not seem to be helpful for arrhythmia risk stratification.
The optimal intensity of vitamin k antagonists in patients with mechanical heart
valves: A meta-analysis
J Am Coll Cardiol 17 December
2003, Volume 42, Issue 12 Pages 2042-2048
Roel
Vink, Roderik A. Kraaijenhagen, Barbara A. Hutten, Renee B. A. van den Brink,
Bas A. de Mol, Harry R. Büller and Marcel Levi
This
meta-analysis shows that both aortic and
mitral valves will benefit from a treatment strategy with a target INR higher
than 3.0.
Clinical efficacy of cardiac resynchronization therapy using left ventricular
pacing in heart failure patients stratified by severity of ventricular
conduction delay
J Am Coll Cardiol 17 December
2003, Volume 42, Issue 12 Pages 2109-2116
Angelo Auricchio, Christoph Stellbrink, Christian Butter, Stefan Sack,
Jürgen Vogt, Anand Ramdat Misier, Dirk Böcker, Michael Block, Johannes H.
Kirkels, Pacing Therapies in Congestive Heart Failure (PATH-CHF) II Study
Group Andrew Kramer, Etienne Huvelle and Guidant Heart Failure Research Group
Left ventricular pacing significantly
improves exercise tolerance and quality of life in patients with chronic HF, LV
systolic dysfunction, and a QRS interval over 150 ms.
Routine vitamin supplementation to prevent cardiovascular disease: a summary of
the evidence for the U.S. preventive services task force
Ann Intern Med 2003;139:51–5
C.D.
Morris and S. Carson
The US Preventive Services Task Force (USPSTF) concluded the evidence is insufficient to
recommend for or against use of supplements of vitamin A, C or E; multivitamins
with folic acid or antioxidant combinations for the prevention of cancer or CV
disease. The USPSTF recommends against use of beta carotene supplements
alone or in combination for the prevention of either cancer or CVD.
Inflammation as
a Risk Factor for Atrial Fibrillation
Circulation. 2003;108:3006
Ronnier J. Aviles, MD; David O. Martin, MD, MPH; Carolyn Apperson-Hansen,
MS; Penny L. Houghtaling, MS; Pentti Rautaharju, MD; Richard A. Kronmal, PhD;
Russell P. Tracy, PhD; David R. Van Wagoner, PhD; Bruce M. Psaty, MD, PhD;
Michael S. Lauer, MD; Mina K. Chung, MD
CRP is not only associated with the
presence of AF but may also predict patients at increased risk for future
development of AF.
Successful Catheter Ablation of Electrical Storm after Myocardial Infarction
Circulation. 2003;108:3011
Dietmar Bänsch, MD; Feifan Oyang, MD; Matthias Antz, MD; Thomas Arentz,
MD; Reinhold Weber, MD; Jesus E. Val-Mejias, MD; Sabine Ernst, MD; Karl-Heinz
Kuck, MD
Incessant ventricular
tachyarrhythmias after MI may be triggered by VPBs. RF ablation of the
triggering VPBs is feasible and can prevent drug-resistant electrical storm,
even after acute MI.
Long QT syndrome patients may faint due to
neurocardiogenic syncope
EUROPACE, October 2003 | Volume 5, Issue 4 | Pages
367-370
E. Toft,J. Aarøe,B.T. Jensen,M. Christiansen,L. Fog,P.E.B. Thomsen,J.K.
Kanters
Syncope in LQTS
can be of neurocardiogenic origin and is not necessarily due to TdP.
Use of enalapril to facilitate sinus rhythm
maintenance after external cardioversion of long-standing persistent atrial
fibrillation
EUROPEAN HEART JOURNAL December 2003 | Volume 24, Issue
23 | Pages 2090-2098
Kwo-Chang Ueng,Tsung-Po Tsai,Wen-Chung Yu,Chin-Feng Tsai,Ming-Cheng
Lin,Kuei-Chuan Chan,Chung-Yin Chen,Der-Jinn Wu,Chung-Sheng Lin,Shih-Ann Chen
The addition of
enalapril to amiodarone decreased the rate of immediate and subacute arrhythmia
recurrences and facilitated subsequent long-term maintenance of sinus rhythm
after cardioversion of persistent AF.
Diazepam or midazolam for external DC cardioversion
(The DORM Study)
EUROPACE October 2003 | Volume 5, Issue 4 | Pages
391-395
A.R.J. Mitchell,S. Chalil,L. Boodhoo,G. Bordoli,N. Patel,N. Sulke
Physician-led
cardioversion of atrial arrhythmias using intravenous sedation is effective and
well tolerated. Sedation with diazepam was associated with fewer minor adverse
events and a quicker recovery time than midazolam.
Chronic periodontitis, a significant relationship
with acute myocardial infarction
EUROPEAN HEART JOURNAL December 2003 | Volume 24, Issue
23 | Pages 2108-2115
G. Rutger Persson,Ola Ohlsson,Thomas Pettersson,Stefan Renvert
Patients who at routine
dental visits demonstrate evidence of bone loss around several teeth can
predictably be identified as being at risk for future AMI.
Walk test at increased levels of heart rate in
patients with dual-chamber pacemaker and with normal or depressed left
ventricular function
EUROPEAN HEART JOURNAL December 2003 | Volume 24, Issue
23 | Pages 2123-2132
Adele
Ferro,Carlo Duilio,Maurizio Santomauro,Alberto Cuocolo
Increasing heart
rate in presence of ventricular asynchrony induced by dual-chamber pacing has
negative effect on cardiac contractility and does not improve CO at rest or
during physical activity in patients with depressed LV function as occurs in
those with normal function.
Comparison of effectiveness of implantable
cardioverter defibrillator in patients with idiopathic dilated cardiomyopathy
versus those with proved coronary heart disease
Am J Cardiol
15 November 2003, Volume 92, Issue 10
Pages 1227-1230
Alejandro Cuesta, Lluís Mont, Ulises Rogel, Mariana Valentino, Mariona Matas
and Josep Brugada
There were no
differences in the type and probability of recurrences at follow-up.
Optimal duration of monitoring in patients with
unexplained syncope
Am J Cardiol
15 November 2003, Volume 92, Issue 10 Pages 1231-1233
Manish D. Assar, Andrew D. Krahn, George J. Klein, Raymond Yee and Allan
C. Skanes
There is a low risk of syncope after 1 year of monitoring without an event.
Water Ingestion as
Prophylaxis Against Syncope
Circulation. 2003;108:2660
Chih-Cherng Lu, MD, MS; André Diedrich, MD, PhD; Che-Se Tung, MD, PhD; Sachin Y.
Paranjape, BS; Paul A. Harris, PhD; Daniel W. Byrne, MS; Jens Jordan, MD; David
Robertson, MD
Water enhances tolerance of upright
posture. The effect of water is
mediated by increased peripheral vascular resistance.
Prevention of atrial fibrillation recurrence by statin therapy in patients with
lone atrial fibrillation after successful cardioversion
Am J Cardiol 1 December 2003,
Volume 92, Issue 11 Pages 1343-1345
Chung-Wah
Siu a, Chu-Pak Lau a and Hung-Fat Tse a
The use of statins was associated with a
significant decrease in the risk of arrhythmia recurrence after successful
cardioversion of AF.
A new oral therapy for long QT syndrome: Long-term oral potassium improves
repolarization in patients with HERG mutations
J Am Coll Cardiol 19 November
2003, Volume 42, Issue 10 Pages 1777-1782
Susan P.
Etheridge, Steven J. Compton, Martin Tristani-Firouzi and Jay W. Mason
Long-term oral potassium
administration increases serum K+ in patients with LQT2. This can be achieved
safely and results in improvement in repolarization.
Depressive symptoms and the risk of sudden cardiac death among the elderly
EUROPEAN HEART JOURNAL November
2003 | Volume 24, Issue 22 | Pages 2021-2026
H.
Luukinen,P. Laippala,H. V. Huikuri
Depressive symptoms increase the risk of
SCD, but not that of non-SCD and non-fatal MI among the elderly subjects.
QT-interval prolongation in right precordial leads: an additional
electrocardiographic hallmark of Brugada syndrome
J Am Coll Cardiol November
2003, Volume 42, Issue 9 Pages 1632-1637
Maria
Vittoria Pitzalis, Matteo Anaclerio, Massimo Iacoviello, Cinzia Forleo, Pietro
Guida, Rossella Troccoli, Francesco Massari, Filippo Mastropasqua, Sandro
Sorrentino, Andrea Manghisi and Paolo Rizzon
In accordance with the
electrophysiological background, the typical ECG pattern of Brugada syndrome is
also characterized by a considerable prolongation of the QT interval in right
precordial leads.
Randomized Controlled Trial of Fixed Rate Versus Rate Responsive Pacing After
Radiofrequency Atrioventricular Junction Ablation: Quality of Life, Ventricular
Refractoriness, and Paced QT Dispersion
Journal of Cardiovascular Electrophysiology Volume 14
Issue 11 Page 1163 - November 2003
HENRY J. DUFF, M.D., SATISH R. RAJ, M.D., DEREK V. EXNER, M.D., M.P.H.,
ROBERT S. SHELDON, M.D., Ph.D., DAN ROACH, Ph.D., L. BRENT MITCHELL, M.D., D.
GEORGE WYSE, M.D., Ph.D., MARGARET MORCK, R.N., and ANNE M. GILLIS, M.D.
Rate responsive pacing results in
electrical remodeling of the ventricle following AV junction ablation, but
exercise capacity was similar in groups with RR-ON or RR-OFF.
Right Ventricular Outflow Versus Apical Pacing in Pacemaker Patients with
Congestive Heart Failure and Atrial Fibrillation
Journal of Cardiovascular Electrophysiology Volume 14
Issue 11 Page 1180 - November 2003
BRUCE S. STAMBLER, M.D., KENNETH A. ELLENBOGEN, M.D., XIAOZHENG ZHANG,
M.D., THOMAS R. PORTER, M.D., FENG XIE, M.D., RAJESH MALIK, M.D., ROY SMALL,
M.D., MARTIN BURKE, D.O., ANDREW KAPLAN, M.D., LAWRENCE NAIR, M.D., MICHAEL
BELZ, M.D., CHARLES FUENZALIDA, M.D., MICHAEL GOLD, M.D., CHARLES LOVE, M.D.,
ARJUN SHARMA, M.D., RUSSELL SILVERMAN, M.D., FELIX SOGADE, M.D., BRUCE VAN
NATTA, M.D., and BRUCE L. WILKOFF, M.D., for the ROVA Investigators
In patients with
CHF, LV dysfunction, and chronic AF,
RVOT and dual-site RV pacing shorten QRS duration but after 3 months do not
consistently improve QOL or other clinical outcomes compared with RVA
pacing.
A Randomized Study of Prophylactic Catheter Ablation in Asymptomatic Patients
with the Wolff–Parkinson–White Syndrome
New Engl J Med Volume
349:1803-1811 November 6, 2003 Number 19
Carlo
Pappone, M.D., Ph.D., Vincenzo Santinelli, M.D., Francesco Manguso, M.D.,
Ph.D., Giuseppe Augello, M.D., Ornella Santinelli, M.D., Gabriele Vicedomini,
M.D., Simone Gulletta, M.D., Patrizio Mazzone, M.D., Valter Tortoriello, M.D.,
Alessia Pappone, M.D., Cosimo Dicandia, M.D., and Salvatore Rosanio, M.D.,
Ph.D.
Prophylactic accessory-pathway ablation
markedly reduces the frequency of arrhythmic events in asymptomatic patients
with the Wolff–Parkinson–White syndrome who are at high risk for such events.
Catheter Ablation for Paroxysmal Atrial Fibrillation Segmental Pulmonary Vein
Ostial Ablation Versus Left Atrial Ablation
Circulation. 2003;108:2355
Hakan
Oral, MD; Christoph Scharf, MD; Aman Chugh, MD; Burr Hall, MD; Peter Cheung,
MD; Eric Good, DO; Srikar Veerareddy, MD; Frank Pelosi, Jr, MD; Fred Morady,
MD
In patients
undergoing catheter ablation for PAF,
LACA to encircle the PVs is more effective than SOCA.
Report of erectile dysfunction after therapy with beta-blockers is related to
patient knowledge of side effects and is reversed by placebo
EUROPEAN HEART JOURNAL November
2003 | Volume 24, Issue 21 | Pages 1928-1932
Antonello Silvestri,Pasquale Galetta,Elena Cerquetani,Giuseppe Marazzi,Roberto
Patrizi,Massimo Fini,Giuseppe M.C. Rosano
The knowledge and prejudice about side
effects of beta-blockers can produce anxiety, that may cause erectile function.
The Influence of High Versus Normal Impedance Ventricular Leads on Pacemaker
Generator Longevity
Pacing and Clinical
Electrophysiology Volume 26 Issue 11 Page 2116 - November 2003
THOMAS
BERGER, FRANZ X. ROITHINGER, HERWIG ANTRETTER*, HERBERT HANGLER*, OTMAR
PACHINGER, and FLORIAN HINTRINGER
Implantation of a high
impedance lead for ventricular pacing results in a clinically relevant extension
of generator longevity.
Death in patients with permanent pacemakers for sick sinus syndrome
Am Heart J November 2003 •
Volume 146 • Number 5
Greg
Flaker, MD, FACC Arnold Greenspon, MD, FACC Barbara Tardiff, MD Eleanor Schron,
MS, RN Lee Goldman, MD, FACC Anne Hellkamp, MS Kerry Lee, PhD Gervasio Lamas,
MD, FACC Mode Selection Trial (MOST) Investigators
After a median follow-up of 33 months,
404 (20%) patients died, including 198 (49%) of noncardiac causes. Patients treated with permanent
pacemakers for sinus node dysfunction are elderly and have a substantial
mortality rate, with more than half the classifiable deaths being noncardiac.
Comparison of Standard Cardiopulmonary Resuscitation Versus the Combination of
Active Compression-Decompression Cardiopulmonary Resuscitation and an
Inspiratory Impedance Threshold Device for Out-of-Hospital Cardiac Arrest
Circulation. 2003;108:2201
Benno B.
Wolcke, MD; Dietmar K. Mauer, MD, PhD; Mark F. Schoefmann, MD; Heinke
Teichmann, MD; Terry A. Provo, BA; Karl H. Lindner, MD, PhD; Wolfgang F. Dick,
MD, PhD; Dorothee Aeppli, PhD; Keith G. Lurie, MD
Compared with
S-CPR, ACD+ITD CPR significantly improved short-term survival rates for patients
with out-of-hospital cardiac arrest. Additional studies are needed to evaluate
potential long-term benefits of ACD+ITD CPR.
Orthostatic headaches without CSF leak in postural tachycardia syndrome
NEUROLOGY 2003;61:980-982
Bahram Mokri, MD and Phillip A. Low, MD
Orthostatic headaches are not always caused by CSF
leak or supine intracranial hypotension. Occasionally they may be the major
clinical manifestation of postural tachycardia syndrome or orthostatic
intolerance.
Unexplained syncope in patients with structural heart disease and no documented
ventricular arrhythmias: value of electrophysiologically guided implantable
cardioverter defibrillator therapy
Europace Volume 5, Issue 3 ,
July 2003, Pages 305-312
T. Pezawas, G. Stix, J. Kastner,
M. Wolzt, C. Mayer, D. Moertl and H. Schmidinger
Syncope per se does
not necessarily herald a bad prognosis. PVS identifies high-risk patients.
Induction of ventricular fibrillation with double or triple extrastimuli is of
limited value. Patients with poor left ventricular function and bad clinical
condition benefit most from an ICD.
Long-Term Complication Rates in Ventricular, Single Lead VDD, and Dual Chamber
Pacing
Pacing and Clinical
Electrophysiology Volume 26 Issue 10 Page 1961 - October 2003
UWE K.H. WIEGAND,
FRANK BODE, HENDRIK BONNEMEIER, FRANK EBERHARD, MONIKA SCHLEI, and WERNER PETERS
Operation time and complication rates of physiological
pacing are reduced by VDD pacemaker implantation.
Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical
therapy
J Am Coll Cardiol 2003, Volume 42, Issue 7 Pages 1161-1170
Robert A. Henderson, Stuart J.
Pocock, Tim C. Clayton, Rosemary Knight, Keith A. A. Fox, Desmond G. Julian,
Douglas A. Chamberlain and Second Randomized Intervention Treatment of Angina
(RITA-2) Trial Participants
An initial
strategy of PTCA did not influence the risk of death or MI, but it improved
angina and exercise tolerance. Patients considered suitable for PTCA or medical
therapy can be safely managed with continued medical therapy, but percutaneous
intervention is appropriate if symptoms are not controlled.
Predictors and Clinical Impact of Atrial Fibrillation After Pacemaker
Implantation in Elderly Patients Treated with Dual Chamber Versus Ventricular
Pacing
Pacing and Clinical
Electrophysiology Volume 26 Issue 10 Page 2000 - October 2003
BRUCE S. STAMBLER, KENNETH A.
ELLENBOGEN, E. JOHN ORAV, ELENA B. SGARBOSSA, N. A. MARK ESTES III, CARLOS RIZO-PATRON,
JAMES B. KIRCHHOFFER, TOM A. HADJIS, LEE GOLDMAN, and GERVASIO A. LAMAS, for the
Pacemaker Selection in the Elderly (PASE) Trial Investigators
DDDR
pacing mode protected against the development of AF.
Chronic Experiences with a Single Lead Dual Chamber Implantable Cardioverter
Defibrillator System
Pacing and Clinical
Electrophysiology Volume 26 Issue 10 Page 1937 - October 2003
MICHAEL NIEHAUS, MARCOS DE
SOUSA, GUNNAR KLEIN, THOMAS KORTE, DIETRICH PFEIFFER, THORSTEN WALLES,
KONSTANTINOS RAYMONDOS, and JUERGEN TEBBENJOHANNS
The first experiences with the new VDD-ICD system show an increase of the
specificity to detect ventricular tachycardias to a level comparable to dual
chamber ICDs with two leads.
Coincidence of idiopathic ventricular outflow tract tachycardia and
atrioventricular nodal reentrant tachycardia
Europace Volume 5, Issue 3 ,
July 2003, Pages 215-220
J. Kautzner, , R. ihák, V.
Vanura and J. Byteník
Coincidence of idiopathic
outflow tract VT and AVNRT was found in 15% of cases of clinically documented
idiopathic VT.
Clinical and electrophysiological characteristics in patients with
atrioventricular reentrant and atrioventricular nodal reentrant tachycardia
Europace Volume 5, Issue 3 ,
July 2003, Pages 225-229
N. Bottoni, C.
Tomasi, P. Donateo, G. Lolli, N. Muià, F. Croci, D. Oddone, C. Menozzi and M.
Brignole
Patients with AVRT
have a lower mean age at arrhythmia symptom onset compared with those with AVNRT
and have fewer associated cardiac abnormalities. Clinical presentation is quite
similar as well as their outcome after ablation.
Comparison of the haemodynamic effects of
right ventricular outflow-tract pacing with right ventricular apex pacing: A
quantitative review
Europace Volume 5, Issue 3 ,
July 2003, Pages 275-278
C. C. de Cock, M. C. Giudici and
J. W. Twisk
Right ventricular outflow-tract
pacing may offer a modest but significant benefit over right ventricular apex
pacing in patients selected for pacemaker implantation on the basis of
symptomatic bradyarrhythmias.
Effects of Eplerenone, Enalapril, and Eplerenone/Enalapril in Patients With
Essential Hypertension and Left Ventricular
Hypertrophy The 4E–Left Ventricular Hypertrophy
Study
Circulation. 2003;108:1831
Bertram Pitt, MD; Nathaniel
Reichek, MD; Roland Willenbrock, MD; Faiez Zannad, MD; Robert A. Phillips, MD;
Barbara Roniker, MD; Jay Kleiman, MD; Scott Krause, BSN; Daniel Burns, BS;
Gordon H. Williams, MD
Eplerenone was as
effective as enalapril in LVH regression and blood pressure control. The
combination of eplerenone and enalapril was more effective in reducing
LV mass and systolic blood pressure than
eplerenone alone.
Prolonged Atrial Action Potential Durations and Polymorphic Atrial
Tachyarrhythmias in Patients with Long QT Syndrome
Journal of Cardiovascular
Electrophysiology Volume 14 Issue 10 Page 1027 - October 2003
PAULUS
KIRCHHOF, M.D., LARS ECKARDT, M.D., MICHAEL R. FRANZ, M.D., Ph.D.*, GEROLD
MÖNNIG, M.D., PETER LOH, M.D., HORST WEDEKIND, M.D., ERIC SCHULZE-BAHR, M.D.,
GÜNTER BREITHARDT, M.D., and WILHELM HAVERKAMP, M.D.
PolyAT appears to be
a specific arrhythmia of LQTS reminiscent of an atrial form of "torsades de
pointes."
QRS duration and prediction of mortality in patients undergoing risk
stratification for ventricular arrhythmias
Am J Cardiol 1 October 2003,
Volume 92, Issue 7 Pages 798-803
Vidyasagar Kalahasti a, Vijay Nambi a, David O. Martin a, Cathy T. Lam b,
David Yamada c, Bruce L. Wilkoff a, Mark J. Niebauer d, Fredrick J. Jaeger a,
Patrick J. Tchou a and Mina K. Chung a
Prolonged QRS duration is a strong
independent marker of long-term mortality in patients who undergo risk
stratification for ventricular arrhythmias.
Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an
independent marker of sudden death risk in young patients
JACC 3 September 2003, Volume
42, Issue 5 Pages 873-879
Lorenzo
Monserrat, Perry M. Elliott, Juan R. Gimeno, Sanjay Sharma, Manuel Penas-Lado
and William J. McKenna
Non-sustained ventricular tachycardia is
associated with a substantial increase in sudden death risk in young patients
with HCM.
Sulfonylureas attenuate electrocardiographic ST-segment elevation during an
acute myocardial infarction in diabetics
JACC 17 September 2003, Volume
42, Issue 6 Pages 1017-1021
Jose F.
Huizar, Luis A. Gonzalez, James Alderman and Harton S. Smith
Sulfonylurea therapy appears to
attenuate the magnitude of ST-segment elevation during an AMI, resulting in
failure to meet criteria for thrombolytic therapy.
Significant gender-related differences in radiofrequency catheter ablation
therapy
JACC 17 September 2003, Volume
42, Issue 6 Pages 1103-1107
Nikolaos
Dagres, Jonathan R. Clague, Günter Breithardt and Martin Borggrefe
Women are referred for ablation later
than are men, after a longer duration of symptoms, and after having been given
more antiarrhythmic drugs.
Comparison of the haemodynamic effects of right ventricular outflow-tract pacing
with right ventricular apex pacing: A quantitative review
Europace Volume 5, Issue 3 ,
July 2003, Pages 275-278
C. C. de
Cock, , 1, M. C. Giudici2 and J. W. Twisk3
Right ventricular outflow-tract pacing
may offer a modest but significant benefit over right ventricular apex pacing
in patients selected for pacemaker implantation on the basis of symptomatic
bradyarrhythmias.
QRS duration: a simple marker for predicting cardiac mortality in ICD patients
with heart failure
Heart 2003;89:1157-1162
L
Bode-Schnurbus1, D Böcker1, M Block1, R Gradaus1, A Heinecke2, G Breithardt1
and M Borggrefe3
Within subgroups at
highest risk of cardiac death, QRS duration—a simple non-invasive index—predicts
outcome in ICD recipients in the presence of heart failure.
Ventricular Flutter Induced During Electrophysiologic Studies in Patients with
Old Myocardial Infarction: Clinical and Electrophysiologic Predictors, and
Prognostic Significance
Journal of Cardiovascular Electrophysiology Volume 14
Issue 9 Page 913 - September 2003
SAMI VISKIN, M.D., MAYA ISH-SHALOM, M.D., EDWARD KOIFMAN, M.D., URI
ROZOVSKI, M.D., DAVID ZELTSER, M.D., AHARON GLICK, M.D., ARIEL FINKELSTEIN,
M.D., AMIR HALKIN, M.D., ROMAN FISH, M.D., and BERNARD BELHASSEN, M.D.
The prognostic
value of inducible ventricular flutter is comparable to that of SMVT.
Are Electrophysiological Studies Needed Prior to Defibrillator Implantation?
Pacing and Clinical
Electrophysiology Volume 26 Issue 8 Page 1715 - August 2003
RUEDIGER
BECKER, MICHAIL MELKUMOV, JULIA C. SENGES-BECKER, FREDERIK VOSS, ALEXANDER
BAUER, JOCHEN MICHAELSEN, SLAWOMIR WERETKA, FERAYDOON NIROOMAND, HUGO A. KATUS,
and WOLFGANG SCHOELS
Based on these retrospective data,
routine electrophysiological study prior to ICD implantation seems to be
advisable.
Analysis of Implantable Cardioverter Defibrillator Therapy in the
Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial
Journal of Cardiovascular Electrophysiology Volume 14
Issue 9 Page 940 - September 2003
RICHARD C. KLEIN, M.D., MERRITT H. RAITT, M.D., BRUCE L. WILKOFF, M.D.,
KAREN J. BECKMAN, M.D., JAMES COROMILAS, M.D., D. GEORGE WYSE, M.D., PETER L.
FRIEDMAN, M.D., JAMES B. MARTINS, M.D., ANDREW E. EPSTEIN, M.D., ALFRED P.
HALLSTROM, Ph.D., ROBERT B. LEDINGHAM, M.S., KAREN M. BELCO, R.N., H. LEON
GREENE, M.D., and The Avid Investigators
An
appropriate shock was delivered in 53%. The first arrhythmia treated in
follow-up was diagnosed as VT (63%), VF (13%), supraventricular tachycardia (18%), unknown arrhythmia (3%), or due to ICD malfunction or inappropriate
sensing (3%). Acceleration of an
arrhythmia by the ICD occurred in 8%.
Mitral Valve Surgery Can Now Routinely Be Performed Endoscopically
Circulation. 2003;108:II-48
Filip P.
Casselman, MD, PhD, FETCS; Sam Van Slycke, MD; Francis Wellens, MD, FETCS;
Raphael De Geest, MD; Ivan Degrieck, MD, FETCS; Frank Van Praet, MD, FETCS;
Yvette Vermeulen, MSc; Hugo Vanermen, MD, FETCS
Endoscopic mitral valve surgery can be
performed safely but definitely requires a learning curve. Good results and a
high patient satisfaction are guaranteed.
Percutaneous Pericardial Instrumentation for Endo-Epicardial Mapping of
Previously Failed Ablations
Circulation. 2003;108:1329
Robert
A. Schweikert, MD; Walid I. Saliba, MD; Gery Tomassoni, MD; Nassir F.
Marrouche, MD; Christopher R. Cole, MD; Thomas J. Dresing, MD; Patrick J.
Tchou, MD; Dianna Bash, RN; Salwa Beheiry, RN; Cathy Lam, MD; Logan
Kanagaratnam, MD; Andrea Natale, MD
Epicardial instrumentation
and ablation appeared feasible and safe and provided an alternative strategy for
the treatment of patients with a variety of arrhythmias.
Clinical and electrophysiological characteristics in patients with
atrioventricular reentrant and atrioventricular nodal reentrant tachycardia
Europace Volume 5, Issue 3 ,
July 2003, Pages 225-229
N.
Bottoni, , 1, C. Tomasi1, P. Donateo2, G. Lolli1, N. Muià1, F. Croci2, D.
Oddone2, C. Menozzi1 and M. Brignole2
Patients with AVRT have a lower mean age
at arrhythmia symptom onset compared with those with AVNRT and have fewer associated cardiac abnormalities. Clinical presentation is quite similar
as well as their outcome after ablation. A correct diagnosis by standard
ECG is more frequent in AVNRT.
High prevalence of right ventricular involvement in endurance athletes with
ventricular arrhythmias
EUROPEAN HEART JOURNAL August
2003 | Volume 24, Issue 16 | Pages 1473-1480
Hein
Heidbüchel, Jan Hoogsteen, Robert Fagard, L. Vanhees, Hugo Ector, Rik Willems, Johan
Van Lierde
Complex ventricular arrhythmias do not
necessarily represent a benign finding in endurance athletes. An
electrophysiological study is indicated for risk evaluation, both by defining
inducibility and identifying the arrhythmogenic mechanism. Endurance athletes
with arrhythmias have a high prevalence of right ventricular structural and/or
arrhythmic involvement. Endurance sports seems to be related to the development
and/or progression of the underlying arrhythmogenic substrate.
Proportion and prognosis of healthy people with coved or saddle-back type ST
segment elevation in the right precordial leads during 10 years follow-up
EUROPEAN HEART JOURNAL August
2003 | Volume 24, Issue 16 | Pages 1488-1493
Masao
Sakabe,Akira Fujiki,Masanao Tani,Kunihiro Nishida,Koichi Mizumaki,Hiroshi
Inoue
The average proportion of healthy
subject who had coved or saddle-back type of ST elevation in the right
precordial leads without family history of sudden death was 1.22% and the risk
of fatal arrhythmias was low (1/393.5 subject-years).
INR Self-Management Permits Lower Anticoagulation Levels After Mechanical Heart
Valve Replacement
Circulation. 2003;108:II-75
H.
Koertke, MD; K. Minami, MD; D. Boethig, MD; Th. Breymann, MD; D. Seifert, MD;
O. Wagner; N. Atmacha, MD; A. Krian, MD; J. Ennker, MD; U. Taborski, MD; W.P.
Klövekorn, MD; R. Moosdorf, MD; W. Saggau, MD; R. Koerfer, MD
Early onset INR
self-management under oral anticoagulation after mechanical heart valve
replacement enables patients to keep within a lower and smaller INR target
range.
Effect of Modern Pacing Algorithms on Generator Longevity: A Predictive Analysis
Pacing and Clinical
Electrophysiology Volume 26 Issue 9 Page 1796 - September 2003
DAN
GELVAN, EUGENE CRYSTAL, BARBAROS DOKUMACI§, YUVAL GOLDSHMID and I. ELI
OVSYSHCHER
Two algorithms: Capture Management and
Search AV, have clinical relevance in the extension of PG longevity.
Radiofrequency Ablation of Probable Atrioventricular Nodal Reentrant Tachycardia
in Children with Documented Supraventricular Tachycardia Without Inducible
Tachycardia
Pacing and Clinical
Electrophysiology Volume 26 Issue 8 Page 1679 - August 2003
STEVEN
B. FISHBERGER
In selected patients, empiric slow
pathway modification may be offered as a potential cure in children with
recurrent paroxysmal SVT who are not inducible at electrophysiological study.
Elimination of slow pathway conduction may serve as a surrogate endpoint, though
is not necessary for long-term success.
Mapping and Ablation of Ventricular Fibrillation Associated With Long-QT and
Brugada Syndromes
Circulation. 2003;108:925
Michel
Haïssaguerre, MD; Fabrice Extramiana, MD; Mélèze Hocini, MD; Bruno Cauchemez,
MD; Pierre Jaïs, MD; Jose Angel Cabrera, MD; Geronimo Farre, MD; Antoine
Leenhardt, MD; Prashanthan Sanders, MBBS; Christophe Scavée, MD; Li-Fern Hsu,
MBBS; Rukshen Weerasooriya, MBBS; Dipen C. Shah, MD; Robert Frank, MD;
Philippe Maury, MD; Marc Delay, MD; Stéphane Garrigue, MD; Jacques Clémenty,
MD
Triggers from the
Purkinje arborization or the right ventricular outflow tract have a crucial role
in initiating ventricular fibrillation associated with the long-QT and Brugada
syndromes. These can be eliminated by focal radiofrequency ablation.
Prediction of sudden cardiac death after myocardial infarction in the
beta-blocking era
J Am Colleg Cardiol 20 August
2003, Volume 42, Issue 4 Pages 652-658
Heikki
V. Huikuri, Jari M. Tapanainen, Kai Lindgren, Pekka Raatikainen, Timo H.
Mäkikallio, K. E. Juhani Airaksinen and Robert J. Myerburg
The common arrhythmia risk variables,
particularly the autonomic and standard ECG markers, have limited predictive
power in identifying patients at risk of SCD after AMI in the beta-blocking era.
A Randomized Prospective Study of Single Coil Versus Dual Coil Defibrillation in
Patients with Ventricular Arrhythmias Undergoing Implantable Cardioverter
Defibrillator Therapy
Pacing and Clinical
Electrophysiology Volume 26 Issue 8 Page 1684 - August 2003
C. ALDO
RINALDI, RON D.B. SIMON, PETER GEELEN , SVEN REEK , ARTUR BASZKO, MARTIN KUEHL
, and JASWINDER S. GILL
No significant
advantage of a dual coil lead system over a single coil system in terms of lead
values and defibrillation thresholds.
Ablate and pace revisited: long term survival and predictors of permanent atrial
fibrillation
Heart 2003;89:1035-1038
A
Queiroga, H J Marshall, M Clune and M D Gammage
Ablate and pace is associated with a low
overall mortality. No predictors of permanent atrial fibrillation were
identified, but 48% of patients were still in sinus rhythm at 72 months. These results support the use of dual
chamber pacing for paroxysmal atrial fibrillation patients after ablate and
pace.
Short QT Syndrome A
Familial Cause of Sudden Death
Circulation. 2003;108:965
Fiorenzo
Gaita, MD; Carla Giustetto, MD; Francesca Bianchi, MD; Christian Wolpert, MD;
Rainer Schimpf, MD; Riccardo Riccardi, MD; Stefano Grossi, MD; Elena Richiardi,
MD; Martin Borggrefe, MD
The short QT syndrome is characterized
by familial sudden death, short refractory periods, and inducible ventricular
fibrillation. It is important to recognize this ECG pattern because it is
related to a high risk of sudden death in young, otherwise healthy subjects.
A randomized comparison of atrial and dual-chamber pacing in 177 consecutive
patients with sick sinus syndrome: Echocardiographic and clinical outcome
J Am Colleg Cardiol 20 August
2003, Volume 42, Issue 4 Pages 614-623
Jens C.
Nielsen, Lene Kristensen, Henning R. Andersen, Peter T. Mortensen, Ole L.
Pedersen and Anders K. Pedersen
During a mean follow-up of 2.9 ± 1.1
years, DDDR pacing causes increased LA
diameter, and DDDR pacing with a short atrioventricular delay also causes
decreased LVFS. No changes occur in LA or LV diameters or LVFS during AAIR
pacing. Atrial fibrillation is significantly less common during AAIR pacing.
Comparison of monophasic and biphasic shocks for transthoracic cardioversion of
atrial fibrillation
Heart 2003;89:1032-1034
M
Scholten, T Szili-Torok, P Klootwijk and L Jordaens
A protocol using monophasic waveform
shocks in a 200–360 J sequence has the same efficacy (90%) as a protocol using
rectilinear biphasic waveform shocks in a 120–200 J sequence.
A new pacemaker algorithm for the treatment of atrial fibrillation: Results of
the Atrial Dynamic Overdrive Pacing Trial (ADOPT)
J Am Colleg Cardiol 20 August
2003, Volume 42, Issue 4 Pages 627-633
Mark D.
Carlson, John Ip, John Messenger, Scott Beau, Steven Kalbfleisch, Pierre
Gervais, Douglas A. Cameron, Aurelio Duran, Jesus Val-Mejias, Judith Mackall,
Michael Gold and ADOPT Investigators
Overdrive atrial pacing with the AF
Suppression Algorithm decreased symptomatic AF burden significantly in patients
with sick sinus syndrome and AF.
The decrease in relative AF burden was substantial (25%), although the absolute
difference was small (2.50% control vs. 1.87% treatment).
Fish Consumption
Is Associated With Lower Heart Rates
Circulation. 2003;108:820
Jean
Dallongeville, MD, PhD; John Yarnell, MD, PhD; Pierre Ducimetière, PhD;
Dominique Arveiler, MD, PhD; Jean Ferrières, MD, MPH; Michèle Montaye, MD;
Gérald Luc, MD; Aluns Evans, MD, PhD; Annie Bingham, MSc; Bernadette Hass, MD;
Jean-Bernard Ruidavets, MD, PhD; Philippe Amouyel, MD, PhD
Fish consumption is associated with
decreased heart rate in men. Because heart rate is positively associated
with risk of sudden death, this association may explain, at least in part, the
lower risk of sudden death among fish consumers.
Effect of 7-Year Infancy-Onset Dietary Intervention on Serum Lipoproteins and
Lipoprotein Subclasses in Healthy Children in the Prospective, Randomized
Special Turku Coronary Risk Factor Intervention Project for Children (STRIP)
Study
Circulation. 2003;108:672
Tuuli
Kaitosaari, MD; Tapani Rönnemaa, MD, PhD; Olli Raitakari, MD, PhD; Sanna
Talvia, MSc; Katariina Kallio, MD; Iina Volanen, MD; Aila Leino, PhD; Eero
Jokinen, MD, PhD; Ilkka Välimäki, MD, MSc; Jorma Viikari, MD, PhD; Olli Simell,
MD, PhD
The 7-year intervention favorably
influenced not only the serum total and LDL cholesterol concentrations but also
the LDL particle size in boys.
Effects of initiating carvedilol in patients with severe chronic heart failure.
Results from the COPERNICUS study
JAMA 2003;289:712–8
H. Krum
, E.B. Roecker , P. Mohacsi and for the Carvedilol Prospective Randomized
Cumulative Survival (COPERNICUS) Study Group.
These data suggest that, in clinically euvolemic
patients, the relation of benefit to risk during early initiation of treatment
with carvedilol is similar to that seen during long-term therapy with the drug.
These findings should provide the reassurance needed to encourage the high
levels of use that are warranted by the results of long-term clinical trials.
The risks of β-blockade
have been significantly overestimated and the benefits underappreciated.
Benefits from carvedilol began to appear about 21 days after its initiation,
supporting both the importance of prompt initiation of therapy and the benefit
of even low doses of carvedilol (as seen in an earlier study of mild to moderate
heart failure). At this point, the
safety criteria utilized in COPERNICUS (clinical euvolemia, no intravenous
inotrope or vasodilator within the prior 4 days) remain a reasonable guideline
for initiation of therapy.
Complications of inappropriate use of spironolactone in heart failure: when an
old medicine spirals out of new guidelines
J Am Coll Cardiol 2003;41:211–4
B.
Bozkurt , I. Agoston and A.A. Knowlton
Complications of hyperkalemia,
hyponatremia and renal insufficiency were far more common in this study of
patients treated with spironolactone in clinical practice compared to patients
in the RALES trial. The RALES investigators reported
serious hyperkalemia (K≥6.0 mEq/L) in 2% of the patients treated with
spironolactone, and did not report less serious degrees of hyperkalemia.
Inhaled beta-2 adrenergic receptor agonists and primary cardiac arrest
Am J Med 2002;113:711–6
R.
Lemaitre , D.S. Siscovick and B.M. Psaty
A two-fold increase in the risk of cardiac
arrest. The increase risk of cardiac arrest is eliminated by the
concomitant use of inhaled steroids.
There are several possible
mechanisms by which inhaled β-agonists may increase the risk of cardiac arrest,
including: precipitation of ischemia in coronary artery disease; lowering of the
ventricular fibrillation threshold; triggering of ventricular tachycardia in
susceptible patients (e.g., prior myocardial infarction, idiopathic ventricular
tachycardia, long-QT syndrome).
Epinephrine unmasks latent mutation carriers with LQT1 form of congenital
long-QT syndrome
J Am Coll Cardiol
2002;41:633–42
W.
Shimizu , T. Noda and H. Takai
Although the sample sizes were
fairly small, the results suggest that an epinephrine challenge may be an
excellent screening tool for family members of a patient identified to have the
LQT1 form of LQTS. If these results are confirmed in larger studies, the
decision to institute prophylactic therapy for family members of probands could
be based simply on the response to epinephrine, rather than on the more
expensive and lengthy process of gene analysis.
Risk stratification in the
long-QT syndrome
N Engl J Med 2003;348:1866–74
S.G.
Priori , P.J. Schwartz and C. Napolitano
The risk of cardiac events in the LQTS is affected by the genotype and is the lowest in patients with LQTS1.
Asymptomatic patients at highest risk of a cardiac event consist of males or females with LQTS1 and a QTc
≥500 ms, males with LQTS2 and a
QTc ≥500 ms, females with LQTS2
(regardless of the QTc) and all
patients with LQTS3.
Complete heart block: determinants and clinical impact in patients with
hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction
therapy
J Am Colleg Cardiol 16 July 2003
(Vol 42, Issue 2) pages 296-300
Su Min
Chang MD, Sherif F. Nagueh MD, William H. Spencer, III MD, and Nasser M. Lakkis
MD
14% developed CHB after the procedure.
Multivariate logistic regression analysis showed that female gender, bolus injection of
ethanol,
injecting more than one septal artery, the presence of left bundle branch block, and first-degree AV
block on the baseline ECG are independent predictors
of CHB after NSRT. Patients with CHB
after NSRT derive similar clinical and hemodynamic benefit to patients who did
not require permanent pacing.
Maintenance of sinus
rhythm in patients with atrial fibrillation: An AFFIRM substudy of the first
antiarrhythmic drug
J Am Colleg Cardiol 2 July 2003 (Vol
42, Issue 1) 20-29
The AFFIRM
First Antiarrhythmic Drug Substudy Investigators
62% were
successfully treated with amiodarone, compared with 23% taking class I agents . In 256 patients randomized between amiodarone and sotalol, 60%
versus 38% were successfully treated, respectively. In 183
patients randomized between sotalol and
class I agents, 34% versus 23% were successfully treated, respectively.
Are lipid-lowering drugs
also antiarrhythmic drugs? an analysis of the antiarrhythmics versus implantable
defibrillators (AVID) trial
|